Clinical Trial Update: Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating concurrent pemetrexed, cisplatin and radiation therapy in stage IIIA/B non-small cell lung cancer; a Phase 1/2 study with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Platinol (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-09-28